{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,24]],"date-time":"2026-07-24T21:06:40Z","timestamp":1784927200257,"version":"3.55.0"},"reference-count":13,"publisher":"Elsevier BV","issue":"8","license":[{"start":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T00:00:00Z","timestamp":1785542400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T00:00:00Z","timestamp":1785542400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,6,3]],"date-time":"2026-06-03T00:00:00Z","timestamp":1780444800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["ajogmfm.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["American Journal of Obstetrics & Gynecology MFM"],"published-print":{"date-parts":[[2026,8]]},"DOI":"10.1016\/j.ajogmf.2026.102013","type":"journal-article","created":{"date-parts":[[2026,6,4]],"date-time":"2026-06-04T23:59:12Z","timestamp":1780617552000},"page":"102013","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"title":["Magnesium sulfate for neuroprotection: Approach to addressing clinical questions"],"prefix":"10.1016","volume":"8","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-8737-407X","authenticated-orcid":false,"given":"Nina K.","family":"Ayala","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dwight J.","family":"Rouse","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"12","key":"10.1016\/j.ajogmf.2026.102013_bib0001","doi-asserted-by":"crossref","first-page":"1494","DOI":"10.1111\/dmcn.15346","article-title":"Global prevalence of cerebral palsy: a systematic analysis","volume":"64","author":"McIntyre","year":"2022","journal-title":"Dev Med Child Neurol"},{"issue":"5","key":"10.1016\/j.ajogmf.2026.102013_bib0002","doi-asserted-by":"crossref","first-page":"334","DOI":"10.1111\/j.1469-8749.2008.02047.x","article-title":"Prevalence, type, distribution, and severity of cerebral palsy in relation to gestational age: a meta-analytic review","volume":"50","author":"Himpens","year":"2008","journal-title":"Dev Med Child Neurol"},{"issue":"2","key":"10.1016\/j.ajogmf.2026.102013_bib0003","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1097\/AOG.0000000000005644","article-title":"Magnesium sulfate before preterm birth for neuroprotection: an updated cochrane systematic review","volume":"144","author":"Shepherd","year":"2024","journal-title":"Obstet Gynecol"},{"issue":"10","key":"10.1016\/j.ajogmf.2026.102013_bib0004","doi-asserted-by":"crossref","first-page":"1180","DOI":"10.1111\/1471-0528.16238","article-title":"Magnesium sulphate for fetal neuroprotection at imminent risk for preterm delivery: a systematic review with meta-analysis and trial sequential analysis","volume":"127","author":"Wolf","year":"2020","journal-title":"BJOG Int J Obstet Gynaecol"},{"issue":"3","key":"10.1016\/j.ajogmf.2026.102013_bib0005","doi-asserted-by":"crossref","first-page":"262","DOI":"10.1515\/jpm-2018-0174","article-title":"Antenatal magnesium sulfate for fetal neuroprotection: a critical appraisal and systematic review of clinical practice guidelines","volume":"47","author":"Jayaram","year":"2019","journal-title":"J Perinat Med"},{"issue":"20","key":"10.1016\/j.ajogmf.2026.102013_bib0006","doi-asserted-by":"crossref","first-page":"2669","DOI":"10.1001\/jama.290.20.2669","article-title":"Effect of magnesium sulfate given for neuroprotection before preterm birth: a randomized controlled trial","volume":"290","author":"Crowther","year":"2003","journal-title":"JAMA"},{"issue":"3","key":"10.1016\/j.ajogmf.2026.102013_bib0007","doi-asserted-by":"crossref","first-page":"310","DOI":"10.1111\/j.1471-0528.2006.01162.x","article-title":"Magnesium sulphate given before very-preterm birth to protect infant brain: the randomised controlled PREMAG trial*","volume":"114","author":"Marret","year":"2007","journal-title":"BJOG Int J Obstet Gynaecol"},{"issue":"9","key":"10.1016\/j.ajogmf.2026.102013_bib0008","doi-asserted-by":"crossref","first-page":"895","DOI":"10.1056\/NEJMoa0801187","article-title":"A randomized, controlled trial of magnesium sulfate for the prevention of cerebral palsy","volume":"359","author":"Rouse","year":"2008","journal-title":"N Engl J Med"},{"issue":"10","key":"10.1016\/j.ajogmf.2026.102013_bib0009","doi-asserted-by":"crossref","first-page":"1217","DOI":"10.1111\/1471-0528.16239","article-title":"Antenatal magnesium sulphate for the prevention of cerebral palsy in infants born preterm: a double-blind, randomised, placebo-controlled, multi-centre trial","volume":"127","author":"Wolf","year":"2020","journal-title":"BJOG Int J Obstet Gynaecol"},{"issue":"7","key":"10.1016\/j.ajogmf.2026.102013_bib0010","doi-asserted-by":"crossref","first-page":"603","DOI":"10.1001\/jama.2023.12357","article-title":"Prenatal intravenous magnesium at 30-34 weeks\u2019 gestation and neurodevelopmental outcomes in offspring: the magenta randomized clinical trial","volume":"330","author":"Crowther","year":"2023","journal-title":"JAMA"},{"issue":"1","key":"10.1016\/j.ajogmf.2026.102013_bib0011","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1111\/anae.14705","article-title":"Trial sequential analysis: adding a new dimension to meta-analysis","volume":"75","author":"Shah","year":"2020","journal-title":"Anaesthesia"},{"issue":"2","key":"10.1016\/j.ajogmf.2026.102013_bib0012","first-page":"185","article-title":"Fetal serum and amniotic fluid magnesium concentrations with maternal treatment","volume":"81","author":"Hallak","year":"1993","journal-title":"Obstet Gynecol"},{"issue":"2 Pt 1","key":"10.1016\/j.ajogmf.2026.102013_bib0013","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1097\/AOG.0b013e31827c5cf8","article-title":"Evaluation of the clinical use of magnesium sulfate for cerebral palsy prevention","volume":"121","author":"Gibbins","year":"2013","journal-title":"Obstet Gynecol"}],"container-title":["American Journal of Obstetrics & Gynecology MFM"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2589933326001126?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2589933326001126?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,7,24]],"date-time":"2026-07-24T20:28:23Z","timestamp":1784924903000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2589933326001126"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,8]]},"references-count":13,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2026,8]]}},"alternative-id":["S2589933326001126"],"URL":"https:\/\/doi.org\/10.1016\/j.ajogmf.2026.102013","relation":{},"ISSN":["2589-9333"],"issn-type":[{"value":"2589-9333","type":"print"}],"subject":[],"published":{"date-parts":[[2026,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Magnesium sulfate for neuroprotection: Approach to addressing clinical questions","name":"articletitle","label":"Article Title"},{"value":"American Journal of Obstetrics & Gynecology MFM","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ajogmf.2026.102013","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Author(s). Published by Elsevier Inc.","name":"copyright","label":"Copyright"}],"article-number":"102013"}}